Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of k18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2 https://www.biorxiv.org/content/10.1101/2023.03.29.534854v1?med=mas
Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of k18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2 https://www.biorxiv.org/content/10.1101/2023.03.29.534854v1?med=mas